September 21, 2022
Gillette Stadium

<< Back to Agenda

Educational Session 2B

4:15 PM – 5:15 PM | East Clubhouse, Red Level Suite 20

 

 

 

 

 

 

Speaker: Stacy Price| VP Technical Operations| Ziopharm

Stacy Price has over twenty years of experience managing organizations and programs for commercial & clinical biotechnology operations.  She has been responsible for establishing and leading efforts to direct operations and programs for a variety of functions including: Tech-transfer, facility startup, cGMP and Pilot Manufacturing, Engineering, CMC, process development, IT applications, and supply chain.  Prior to working at Ziopharm, Stacy was the Head of Operations in the Process Development organization, at Shire Pharmaceuticals, leading business and laboratory groups through strategic planning & execution. Stacy holds a Master of Science in Biochemical Engineering from Tufts University.  She is a Project Management Professional (PMP), has a green belt in Lean Six Sigma and holds a certification in Business Process Management.

 

 

 

 

 

Speaker: Katie Shannon |Head of Engineering | Brammer Bio, a part of Thermo Fisher Scientific

Katie Shannon, Head of Engineering at Brammer Bio, a part of Thermo Fisher Scientific, has over 17 years of biopharmaceutical engineering experience spanning new facility construction through commercial manufacturing support.  In her current role, she’s responsible for capital portfolio/project management, engineering technical services, global engineering/CQV standards, asset management, real estate, and site services.  Katie has successfully overseen the conversion of a protein biologics manufacturing facility to a gene therapy viral vector operation with additional capacity expansion projects in progress.  Previously, she held roles at Biogen and Sanofi Pasteur.  Katie graduated from Lehigh University with a BS, Chemical Engineering and University of Wisconsin-Madison with an ME, Engineering Management.  She’s an active member of the ISPE Women in Pharma Boston Chapter.

 

 

 

 

 

Speaker: Michael Paglia |Sr. Vice President, CMC Operations | ElevateBio

Michael has spent his career in biotechnology building, leading, and motivating process development and manufacturing teams to support clinical programs from early development to late stage clinical trials. Michael has been responsible for process development and analytics, cGMP manufacturing operations, CMC regulatory strategy, cellular procurement, and process characterization and validation activities for multiple novel viral, cell and gene therapy products. Currently, Michael is Sr. Vice President of CMC Operations at ElevateBio leading process development, manufacturing and CMC regulatory for a broad portfolio of gene and cell therapy products.  Prior to ElevateBio, Michael was the Vice President of CMC operations at Oncorus and bluebird bio as the Sr. Director of Technical Operations and head of Cellular Process Development and Manufacturing Operations.